Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-002257

CEO and CFO bought 1,500 shares at $17.37 ($26,055)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-01-20 Purchase +1,500 $17.37 $26,055 2,732,886 D
Open-market purchases · 1,500 sh · avg $17.37 · $26,055
Loading xslF345X03/ownership.xml…